Treatment Patterns and Outcomes in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents: A SEER-Medicare Analysis

被引：4
|
作者：
Stein, Eytan M. [1 ]
Latremouille-Viau, Dominick [2 ]
Joseph, George J. [3 ]
Shi, Sherry [2 ]
Guerin, Annie [2 ]
Wu, Eric Q. [4 ]
Bonifacio, Gaetano [3 ]
Cao, Xiting [3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Anal Grp Inc, Montreal, PQ, Canada
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Anal Grp Inc, Boston, MA USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-124878
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3495
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Follicular lymphoma treatment patterns between 2000 and 2014: a SEER-Medicare analysis of elderly patients
    Albarmawi, Husam
    Nagarajan, Madhuram
    Onukwugha, Eberechukwu
    Gandhi, Aakash Bipin
    Keating, Karen N.
    Appukkuttan, Sreevalsa
    Yared, Jean
    FUTURE ONCOLOGY, 2020, 16 (08) : 353 - 366
  • [32] Beyond hypomethylating agents failure in patients with myelodysplastic syndromes
    Zeidan, Amer M.
    Kharfan-Dabaja, Mohamed A.
    Komrokji, Rami S.
    CURRENT OPINION IN HEMATOLOGY, 2014, 21 (02) : 123 - 130
  • [33] Meta-analysis on hypomethylating agents in myelodysplastic syndromes
    Herbst, Christine
    Baner, Kathrin
    Kreuzer, Karl-Anton
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (02): : 342 - 343
  • [34] Evaluation of Bleeding and Thrombocytopenia in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents: A Systematic Review
    Yang, Jiayu
    Choi, Nora
    Paulson, Kristjan
    Sanford, David
    Mozessohn, Lee
    Houston, Donald S.
    Rimmer, Emily
    Lother, Sylvain
    Mendelson, Asher
    Garland, Allan
    Buckstein, Rena
    Hay, Annette E.
    Zarychanski, Ryan
    Houston, Brett L.
    BLOOD, 2022, 140 : 12315 - 12316
  • [35] Are elderly HNSCC patients undertreated? An analysis of outcomes using the SEER-Medicare database
    Suzuki, I.
    Cullen, K.
    Bentzen, S.
    Goloubeva, O.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 23 - 23
  • [36] Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents
    Zeidan, Amer M.
    Hu, Xin
    Zhu, Weiwei
    Stahl, Maximilian
    Wang, Rong
    Huntington, Scott F.
    Giri, Smith
    Bewersdorf, Jan Philipp
    Podoltsev, Nikolai A.
    Gore, Steven D.
    Ma, Xiaomei
    Davidoff, Amy J.
    LEUKEMIA & LYMPHOMA, 2020, 61 (02) : 397 - 408
  • [37] Patterns of care and outcomes in carcinoma of unknown primary: A SEER-Medicare study
    Mileshkin, L.
    Bochtler, T.
    Beringer, A.
    Mueller-Ohldach, M.
    Surinach, A.
    Perret, C.
    Thomas, M.
    Gondos, A.
    Kraemer, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S459 - S459
  • [38] Surveillance Patterns and Survival in Hepatocellular Carcinoma: A Seer-medicare Analysis
    Papageorge, Marianna V.
    de Geus, Susanna W.
    Woods, Alison P.
    Ng, Sing Chau
    McAneny, David
    Tseng, Jennifer F.
    Kenzik, Kelly M.
    Sachs, Teviah E.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 391 - 391
  • [39] Treatment Sequence of Lenalidomide (LEN) and Hypomethylating Agents (HMAs) and the Impact on Clinical Outcomes for Patients with Myelodysplastic Syndromes (MDS)
    Zeidan, Amer M.
    Klink, Andrew J.
    Feinberg, Bruce
    McGuire, Michael
    BLOOD, 2017, 130
  • [40] Patterns of Enteral Feeding Access in Esophagectomy: An Analysis of SEER-Medicare
    Lorimer, Patrick D.
    Walsh, Kendall
    Han, Yimei
    Crimaldi, Anthony J.
    Hill, Joshua S.
    Salo, Jonathan C.
    GASTROENTEROLOGY, 2016, 150 (04) : S1227 - S1227
12345